Autopsy report · NCT05995236
Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy
Cause of deathOther
“So far, we have not been able to collect meaningful data for these patients which also led to our decision to close this study before attempting write up and publish any results”
Life of this trial
- Ran for about 2 years 11 months before it stopped.
- 35 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Methodist Health System
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- PSMA radionuclide therapy
- Participants
- 35
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies
“The study was interrupted early and terminated when only 26 out of 80 patients were enrolled due to new clinical study results indicating that the current study would not be informative.” - Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
“The study was stopped due to difficulties in including patients” - Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
“the patients are now followed in another hospital. The study is discontinued” - Ischemic Stroke and Early Vertical Positioning (SEVEL)
“The required number of patients was not reached. The sites were not able to include more patients.Despite several actions the stop of the study has been decided” - Reiki for the Management of Neuropathic Pain
“Study closed due to substantial decrease in the desired patient population.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.